Altraz
Altraz

3.92
For patients managing hormonal and menopause conditions and oncology care, this generic medicine reduces estrogen production by inhibiting the aromatase enzyme.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Anastrozole
Reference Brand
Anastrozole
Product Origin
Generic Brand
Product Manufacturer
Alkem Laboratories Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones, Oncology Support
Product Category
Nonsteroidal Aromatase Inhibitor
Pharmacological Class
Aromatase Inhibitor
Clinical Indications
Manufacturer Description
Designed to support hormone balance to manage neoplastic cell growth and alleviate tumor development risk.
Mechanism of Action
Inhibits the aromatase enzyme, which blocks peripheral estrogen synthesis in postmenopausal women to limit tumor fuel.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Pregnancy, Hypersensitivity to anastrozole
Severe Adverse Events
Anaphylaxis — requires immediate medical attention, Ischemic cardiovascular events — requires immediate medical attention
Common Side Effects
Hot flashes, Joint pain, Headache
Uncommon Side Effects
Osteoporosis, Elevated cholesterol, Weakness
Drug Interactions
Tamoxifen, Estrogen-containing products
Pregnancy Safety Warnings
TGA Category X: Strictly contraindicated. Can cause fetal mortality. Breastfeeding: Avoid.
Age Restrictions
Approved for postmenopausal females.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Altraz is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to purchase Sleep Aid Tablets - Lunesta Generic